SCHEMBL23152129

SCHEMBL23152129

O=C(OCN1CCNCC1)N1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.50
CHKA P35790 1/20 0.50
CHRM5 P08912 2/20 0.38
CHRM3 P20309 2/20 0.38
SIGMAR1 Q99720 1/20 0.38
ALDH1A1 P00352 3/20 0.38
POLB P06746 1/20 0.38
PADI1 Q9ULC6 1/20 0.36
PADI4 Q9UM07 1/20 0.36
BIRC2 Q13490 1/20 0.35
THRB P10828 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
F2R P25116 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14163283 0.87 ALDH1A1 (0.44) ALDH1A1POLBTHRBATML3MBTL1
SCHEMBL28762420 0.77 CHRM5 (0.40) CA2CHKACHRM5CHRM3SIGMAR1
SCHEMBL29010574 0.75 CHRM5 (0.39) CA2CHKACHRM5CHRM3SIGMAR1
SCHEMBL29437665 0.75 CA2 (0.65) CA2CHKASIGMAR1ALDH1A1POLB
SCHEMBL28762422 0.73 MEN1 (0.39) CA2CHRM5CHRM3SIGMAR1ALDH1A1
SCHEMBL1143951 0.73 TSHR (0.50) CA2CHKAALDH1A1POLBTHRB
SCHEMBL28965503 0.72 ITGB3 (0.58) CA2CHKACHRM3ALDH1A1THRB
Hydrochloric Acid SCHEMBL27453248 0.72 CHRM5 (0.41) CA2CHRM5CHRM3SIGMAR1ALDH1A1
SCHEMBL254801 0.72 GAA (0.67) CA2CHKACHRM5CHRM3SIGMAR1
SCHEMBL19066161 0.72 CA2 (0.55) CA2CHKAALDH1A1POLBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024120442-A1 PAK4 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS CONVERGEN (SUZHOU) PHARMACEUTICAL CO., LTD. (CN) 2024-06-13 WO disclosed
WO-2022143856-A1 DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2022-07-07 WO disclosed
WO-2021058017-A1 DEGRADATION OF ANDROGEN RECEPTOR (AR) BY CONJUGATION OF AR ANTAGONISTS WITH E3 LIGASE LIGAND AND METHODS OF USE BEIGENE, LTD. (KY) 2021-04-01 WO disclosed